Leopoldina Home Menü

Leopoldina Home

News | Tuesday, 3 January 2023

Understanding Long Covid: Leopoldina International Virtual Panel discusses the latest research

Understanding Long Covid: Leopoldina International Virtual Panel discusses the latest research

Image: Adobe Stock | Zerbor

Most people recover quickly and fully from a SARS-CoV-2 infection. However, some patients continue to experience symptoms weeks or even months after the acute stage of infection. This phenomenon is known as “Long Covid”. In order to better understand the science behind Long Covid, a large number of studies have been initiated at the national and international level. Experts will discuss the latest research at an international virtual podium discussion on Tuesday, 24 January 2023 hosted by the Leopoldina.

The Leopoldina International Virtual Panel (LIVP) will focus on the latest research regarding the causes and symptoms of Long Covid. It will also discuss evidence-based strategies for preventing long-term consequences of SARS-CoV-2 infection and for treating and supporting patients with Long Covid. The Leopoldina will welcome the following experts to the podium.

  • Prof. Michael Edelstein, MD, Associate Professor of Epidemiology and Public Health, Bar-Ilan University, Safed, Israel
  • Prof. Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and Molecular, Cellular, and Developmental Biology, Yale University, New Haven, United States
  • Prof. Marc Lecuit, MD, PhD, Director of the Biology of Infection Unit, Institut Pasteur, Paris, France
  • Prof. Dr. Carmen Scheibenbogen, Acting Director of the Institute of Medical Immunology, Charité Universitätsmedizin Berlin, Germany

This event is part of the Leopoldina’s “International Panel Series”, organised in cooperation with its international partners. The virtual panels provide a space for dialogue between leading scientists and the general public. Previous topics addressed were health behaviour, vaccinations, multimorbidity, mental health, contact tracing, and the role of data collection in the context of the COVID-19 pandemic.